𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trials and biomarker research on lung cancer in China

✍ Scribed by Wu, Yi-long; Zhou, Qing

Book ID
125531696
Publisher
Informa plc
Year
2012
Tongue
English
Weight
207 KB
Volume
16
Category
Article
ISSN
1472-8222

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predictors of enrollment in lung cancer
Predictors of enrollment in lung cancer clinical trials
✍ Wei Du; Shirish M. Gadgeel; Michael S. Simon πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Abstract ## BACKGROUND Clinical trials may offer patients innovative therapeutic options with potentially better outcomes, which are particularly relevant for patients afflicted with lung carcinoma, because current therapies provide only modest survival benefits. Only approximately 5% of patien

Biomarker discovery in lung cancerβ€”promi
Biomarker discovery in lung cancerβ€”promises and challenges of clinical proteomics
✍ Ajit Bharti; Patrick C. Ma; Ravi Salgia πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 263 KB

## Abstract Lung cancer is a devastating illness with an overall poor prognosis. To effectively address this disease, early detection and novel therapeutics are required. Early detection of lung cancer is challenging, in part because of the lack of adequate tumor biomarkers. The goal of this review